“While various scenarios are being built on the possible impact of tariff policies, they are unlikely to change the long-term India growth story”, affirms Kailash Kulkarni, Chief Executive Officer, HSBC Mutual Fund
“While various scenarios are being built on the possible impact of tariff policies, they are unlikely to change the...
Indian pharmaceutical stocks surged 5 per cent on Thursday, defying a broader market decline, following the U.S. administration's decision to exempt pharmaceutical products from new reciprocal tariffs.
Indian pharmaceutical stocks surged 5 per cent on Thursday, defying a broader market decline, following the U.S....